7 pointers for infliximab prescribing

The Australian Rheumatology Association has sent a letter to its members warning them to be vigilant when prescribing infliximab for conditions like rheumatoid arthritis.

The letter says the infliximab biosimilar Inflectra has been listed on the PBS for all indications previously approved for originator infliximab, marketed as Remicade, since December 1.

But the PBAC has also made the decision